Demonstrating the affordability of new therapies is crucial in securing reimbursement and market entry. But BIM expectations are changing. Learn exactly how to influence decisions with this practical guide to budget impact analysis in market access.
GUIDE
A Practical Guide to Creating Effective Budget Impact Models in Pharma & MedTech
How effective budget impact analysis drives reimbursement & coverage decisions, strengthening market access
Why this guide is a must-have
- Explains how to strengthen your value story by applying pharmacoeconomics principles
- Provides working examples of how budget impact models (BIMs) are used by decision makers
- Gain best practice steps for developing structured, credible BIMs
- Learn how to avoid weak, unsubstantiated insights
Key failures that jeopardize cost-effectiveness analysis in healthcare
❌ Creating overcomplicated models that are difficult to validate, adapt, or explain to stakeholders
❌ Using a one-size-fits-all approach: failure to customize scenarios, cost perspectives and population inputs (causing misalignment with payer expectations)
❌ Lack of traceability, including poorly documented and inconsistent assumptions
❌ Inconsistencies & poor version control across multiple payer versions
What you’ll learn in this guide:
How to implement the key principles of pharmacoeconomics:
- designing a robust budget impact analysis framework
Best practices for effective and credible BIMs
Do’s and don’ts of creating a BIM:
- what to include / leave out
- when to make updates
BIM expectations in the US vs. Europe
The importance of adapting budget impact analysis to different payer perspectives and territories:
- tailoring models to reflect regional policies, reimbursement structures, and decision criteria
Demonstrating financial impact under different assumptions
Get the best practice insights you need to deliver cost–effectiveness analysis in healthcare that supports market access. Download the guide.
Download the guide
Submit the form below to download your guide.
About the author
Christian Pichardo
Director, Product Management
Christian Pichardo serves as Director of Product Management at Certara/BaseCase. He leads the design and strategic direction of digital solutions that strengthen health economics and value communication, ensuring alignment with customer needs and market trends.
Before stepping into his current role, Mr. Pichardo spent more than 15 years working across the life sciences, consulting, and software industries, holding leadership roles in market access, health economics, and product strategy. In addition to his corporate experience, he has co-founded consulting ventures focused on healthcare innovation and capability development, further broadening his perspective on advancing access and value in healthcare.
About Certara
Certara is dedicated to transforming drug discovery and development for good. We harness the power of biosimulation, advanced analytics, and regulatory expertise to create a future where treatments reach patients faster and more efficiently.
From discovery to market access and commercial, we tailor solutions to meet our clients’ most pressing challenges. Through strategic leadership and advanced predictive technologies, Certara provides comprehensive solutions to optimize drug development processes, reduce risks, and improve outcomes. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.
© 2025 Certara. All Rights Reserved. | Privacy policy